Description: Explore the value and cost of prescription drugs, how they should be defined and measured and the effects various stakeholders in the pharmacy ecosystem can have on these factors in the latest webcast. You'll investigate the impact of coverage, formulary and rebate negotiations and related benefit design. Find out how actuaries can answer questions related to the prescription drug industry, in addition to improving the access, quality and affordability of prescription drugs in the United States. Join us for this webcast and come learn about value-based contract design, negotiations, implementation and administration for prescription drugs.

Description: Artificial intelligence is rapidly transforming the investment landscape. From natural language processing and large language models to physical AI applications like robotics, autonomous vehicles, and drones, the evolution of AI is reshaping both how we analyze data and where we find opportunity. We’ll begin by exploring the evolution of AI, which is already driving disruption across industries such as coding, customer service, and marketing. However, the future of AI is physical AI (drones, AVs, robotics). With valuations already stretched, and growing concerns about the “circular economy” and bubble risks, investors should focus on high-quality tech companies that generate free cash flow and deliver strong returns on invested capital. We'll explore examples of interesting companies across the globe: Meta, Alphabet, and Uber in the US; ASML in Europe; Tokyo Electron in Japan; TSMC in Taiwan; and BYD in China. The session will also examine how natural language processing and large language models are reshaping the way quantitative and fundamental managers extract insights from raw data. We’ll highlight how these tools are being deployed to enhance understanding of risk and return, and how they’re increasingly supporting collaboration between quant and fundamental teams.